Risk score to predict serious bleeding in stable outpatients with or at risk of atherothrombosis
Open Access
- 24 February 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 31 (10), 1257-1265
- https://doi.org/10.1093/eurheartj/ehq021
Abstract
To develop a risk score to quantify bleeding risk in outpatients with or at risk of atherothrombosis. We studied patients in the REACH Registry, a cohort of 68 236 patients with/at risk of atherothrombosis. The outcome of interest was serious bleeding (non-fatal haemorrhagic stroke or bleeding leading to hospitalization and transfusion) over 2 years. Risk factors for bleeding were assessed using modified regression analysis. Multiple potential scoring systems based on the least complex models were constructed. Competing scores were compared on their discriminative ability via logistic regression. The score was validated externally using the CHARISMA population. From a final cohort of 56 616 patients, 804 (1.42%, 95% confidence interval 1.32–1.52) experienced serious bleeding between baseline and 2 years. A nine-item bleeding risk score (0–23 points) was constructed (age, peripheral arterial disease, congestive heart failure, diabetes, hypertension, smoking, antiplatelets, oral anticoagulants, hypercholesterolaemia). Observed incidence of bleeding at 2 years was: 0.46% (score ≤6); 0.95% (7–8); 1.25% (9–10); 2.76% (≥11). The score's discriminative performance was consistent in CHARISMA and REACH (c-statistics 0.64 and 0.68, respectively); calibration in the CHARISMA population was very good (modified Hosmer-Lemeshow c2 = 4.74; P = 0.69). Bleeding risk increased substantially with a score >10. This score can assist clinicians in predicting the risk of serious bleeding and making decisions on antithrombotic therapy in outpatients.This publication has 25 references indexed in Scilit:
- Dual Antithrombotic Therapy Increases Severe Bleeding Events in Patients With Stroke and Cardiovascular DiseaseStroke, 2008
- Development and validation of a prognostic risk score for major bleeding in patients undergoing percutaneous coronary intervention via the femoral approachEuropean Heart Journal, 2007
- External Validity of Clinical Trials in Acute Myocardial InfarctionArchives of Internal Medicine, 2007
- Adverse Impact of Bleeding on Prognosis in Patients With Acute Coronary SyndromesCirculation, 2006
- The REduction of Atherothrombosis for Continued Health (REACH) Registry: An international, prospective, observational investigation in subjects at risk for atherothrombotic events-study designAmerican Heart Journal, 2006
- Clinical classification schemes for predicting hemorrhage: Results from the National Registry of Atrial Fibrillation (NRAF)American Heart Journal, 2006
- External validity of randomised controlled trials: “To whom do the results of this trial apply?”The Lancet, 2005
- Internal validation of predictive models: Efficiency of some procedures for logistic regression analysisJournal of Clinical Epidemiology, 2001
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)Jama-Journal Of The American Medical Association, 2001
- An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial InfarctionThe New England Journal of Medicine, 1993